State of New Jersey Common Pension Fund D trimmed its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 0.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 24,771 shares of the biotechnology company’s stock after selling 92 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Axon Enterprise were worth $20,509,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. TCTC Holdings LLC boosted its position in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after acquiring an additional 24 shares during the last quarter. Bartlett & CO. Wealth Management LLC raised its stake in Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after purchasing an additional 33 shares in the last quarter. Banque Transatlantique SA bought a new stake in Axon Enterprise during the first quarter valued at approximately $31,000. Catalyst Capital Advisors LLC purchased a new position in Axon Enterprise in the 1st quarter worth approximately $32,000. Finally, Flaharty Asset Management LLC bought a new position in shares of Axon Enterprise in the 1st quarter worth $33,000. 79.08% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other Axon Enterprise news, CFO Brittany Bagley sold 5,000 shares of the business’s stock in a transaction dated Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the transaction, the chief financial officer owned 93,592 shares in the company, valued at approximately $66,813,456.96. The trade was a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the sale, the chief executive officer owned 3,053,982 shares of the company’s stock, valued at approximately $2,538,744,696.78. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 59,932 shares of company stock valued at $45,115,616 over the last quarter. Company insiders own 4.40% of the company’s stock.
Analysts Set New Price Targets
View Our Latest Research Report on AXON
Axon Enterprise Trading Up 2.7%
NASDAQ AXON opened at $735.95 on Friday. The firm has a market cap of $57.77 billion, a PE ratio of 181.72, a price-to-earnings-growth ratio of 28.58 and a beta of 1.41. Axon Enterprise, Inc has a 1-year low of $422.38 and a 1-year high of $885.91. The stock has a 50-day moving average of $733.17 and a 200-day moving average of $725.28. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. During the same period in the previous year, the firm earned $1.20 EPS. The business’s quarterly revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- What does consumer price index measure?
- Tractor Supply Stock Looks Like a Buy-and-Hold Winner
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Stocks Well Below 52-Week Highs Poised for a Q4 Rebound
- What Are Trending Stocks? Trending Stocks Explained
- Big Banks Are Setting the Tone as Earnings Season Kicks Off
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
